🌎 Seer Initiated, Arcturus Therapeutics Downgraded, Amgen Initiated and more...

Ratings changes for Silverback Therapeutics, Xeris Pharmaceuticals, Intra-Cellular Therapies, Silverback Therapeutics, Veeco Instruments, Cerner, Healthpeak Properties and more...Add MarketBeat to your address book or safe-sender list to make sure that your newsletter gets delivered to your inbox every time. Click here to learn how. Unsubscribe.

VIEW MY PORTFOLIO

December 29th, 2020

10X SOLUTION (ad) Morgan Stanley says lithium supply needs to jump 10x in four years. But there's a problem. While there's plenty of lithium, there are no new mines. But…new research reveals a young company with a massive lithium property in the heart of the Lithium Triangle You can get your free report here Today's Top Stories Boeing (NYSE:BA) On Watch After 737 MAX Takes Flight Is the Marriott (NASDAQ: MAR) Rally Sustainable? What stocks should you focus on in 2021? (ad) New Philip Morris (NYSE: PM) CEO Plans to Keep Company Moving Towards "Smoke-Free Future" Why Has GameStop (NYSE: GME) Popped 75% This Month? 8 EV Stocks To Electrify Your Growth Portfolio Macy's (NYSE: M) Catches Its First Upgrade Since Before COVID-19 Three High-Yield Dividend Stocks For 2021 And Beyond One Stock to Buy Next Monday Morning (ad) Velodyne Lidar(NASDAQ: VLDR) Stock is a Real Autonomous Vehicle Play Here's Where to Scale into SolarWinds (NYSE: SWI) Stock at Bargain Prices 7 Food Stocks That Are Leading Through Innovation Quick Links My MarketBeat Account Settings Analyst Ratings Company Profiles Dividend Declarations Earnings Announcements Headlines Insider Trades Insider Buying Stocks Insider Selling Stocks The Marijuana Gold Rush Is Here... (ad) Sweeping new legalization could make investors wealthy. FREE Pot Stock Profit Calendar reveals key dates for investors. And it's yours FREE today. Click here to download it instantly... Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. How to Make Money With Options, Detailed Here... (ad) Simple Options Trading for Beginners retails on Amazon for $19.95 and has 4 out of 5 stars. It was written by a stock market trading veteran with over 44 years of experience. Because of a special promotion, this book is 100% FREE for you today. So get it here now... Analysts' Downgrades Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $43.28. Read More. Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $46.00 price target on the stock, down previously from $68.00.This represents a 6.3% upside from the current price of $43.28. Read More. Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $69.00 price target on the stock, down previously from $79.00.This represents a 59.4% upside from the current price of $43.28. Read More. Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $50.00 price target on the stock, down previously from $84.00.This represents a 15.5% upside from the current price of $43.28. Read More. China Southern Airlines (NYSE:ZNH) was downgraded by analysts at Daiwa Capital Markets from a "buy" rating to a "neutral" rating.The current price is $29.04. Read More. View today's most recent analysts' downgrades at MarketBeat.com An Extra $67K+ a Year as a Side Hustle? Yes Please! (ad) Jim Fink is known as the 85% accurate trader. He consistently makes profits with options trading. His unique twist in his strategy could hand you an extra $67,548 a year. Get the full details here! Continue Reading Analysts' New Coverage Amgen (NASDAQ:AMGN) is now covered by analysts at Daiwa Capital Markets. They set a "buy" rating and a $300.00 price target on the stock.This represents a 32.3% upside from the current price of $226.83. Read More. Amphenol (NYSE:APH) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.The current price is $129.44. Read More. Caesarstone (NASDAQ:CSTE) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock.The current price is $12.90. Read More. INVO Bioscience (OTCMKTS:INVO) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.The current price is $3.00. Read More. INVO Bioscience (NASDAQ:INVO) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.The current price is $3.12. Read More. Ormat Technologies (NYSE:ORA) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $96.00 price target on the stock.This represents a 5.2% upside from the current price of $91.23. Read More. Porch Group (NASDAQ:PRCH) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $24.00 price target on the stock.This represents a 65.6% upside from the current price of $14.49. Read More. Silverback Therapeutics (NASDAQ:SBTX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $44.00 price target on the stock.This represents a 20.1% upside from the current price of $36.64. Read More. Silverback Therapeutics (NASDAQ:SBTX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.This represents a 58.3% upside from the current price of $36.64. Read More. Silverback Therapeutics (NASDAQ:SBTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $43.00 price target on the stock.This represents a 17.4% upside from the current price of $36.64. Read More. Silverback Therapeutics (NASDAQ:SBTX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $40.00 price target on the stock.This represents a 9.2% upside from the current price of $36.64. Read More. Seer (NASDAQ:SEER) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $65.00 price target on the stock.This represents a 14.4% upside from the current price of $56.84. Read More. Seer (NASDAQ:SEER) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $69.00 price target on the stock.This represents a 21.4% upside from the current price of $56.84. Read More. Seer (NASDAQ:SEER) is now covered by analysts at Cowen Inc. They set an "outperform" rating on the stock.The current price is $56.84. Read More. Seer (NASDAQ:SEER) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $75.00 price target on the stock.This represents a 31.9% upside from the current price of $56.84. Read More. Sigilon Therapeutics (NASDAQ:SGTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $60.00 price target on the stock.This represents a 56.3% upside from the current price of $38.40. Read More. Sigilon Therapeutics (NASDAQ:SGTX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $48.00 price target on the stock.This represents a 25.0% upside from the current price of $38.40. Read More. Sigilon Therapeutics (NASDAQ:SGTX) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $45.00 price target on the stock.This represents a 17.2% upside from the current price of $38.40. Read More. Tenax Therapeutics (NASDAQ:TENX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $5.00 price target on the stock.This represents a 111.0% upside from the current price of $2.37. Read More. 17 Education & Technology Group (NYSE:YQ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $21.00 price target on the stock.This represents a 52.4% upside from the current price of $13.78. Read More. 17 Education & Technology Group (NYSE:YQ) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.The current price is $13.78. Read More. View today's most recent analysts' new coverage at MarketBeat.com More Calendars from MarketBeat U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume. Upgrade Your Subscription Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact us via email at contact@marketbeat.com or leave us a voice mail at (844) 978-6257. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2020 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.